Elsa Zerbini
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Elsa Zerbini has a total of 125 co-authors. Here are the top co-authors by number of shared publications:
M D Sequeira
4 shared publicationsG Tonarelli
3 shared publicationsM S Imaz
Instituto Nacional de Enfermedades Respiratorias Emilio Coni, ANLIS C. Malbran, Santa Fe, Argentina
3 shared publicationsO Latini
3 shared publications- Alvaro Sebastian Siano
Laboratorio de Peptidos Bioactivos, Department of Organic Chemistry, Faculty of Biochemistry and Biological Sciences, National University of the Littoral, Ciudad Universitaria UNL, 3000 Santa Fe, Argentina; National Scientific and Technical Research Council (CONICET), Ministry of Science, Technology and Innovation, Godoy Cruz 2290, Ciudad de Buenos Aires, Argentina
2 shared publications D Larpin
2 shared publications
Latest Publications
- Open Access
- 12 March 2025
- Published by Universidad de San Martin de Porres in Horizonte Médico (Lima)
- Vol. 25 (1) , e2923
Seroprevalencia de infección por SARS-COV-2 en personal de salud del Gran Santa Fé (Argentina) durante la pandemia de COVID-19
Objetivo: Estimar la prevalencia de infección por el coronavirus del síndrome respiratorio agudo grave de tipo 2 (SARS-CoV-2) mediante la determinación de anticuerpos en Personal de Salud (PS) del Gran Santa Fe (Argentina), en una fase de circulación viral sostenida y una fase de remisión. Materiales y Métodos: Se realizó un estudio longitudinal, seroepidemiológico y de base poblacional. La población objetivo estuvo constituida por el PS que se desempeñó en establecimientos de salud del subsector público, de segundo y tercer nivel, dentro del Gran Santa Fe. El tamaño muestral fue de 600 trabajadores de la salud activos, distribuidos proporcionalmente entre los establecimientos de salud seleccionados. Se aplicó un cuestionario autoadministrado para obtener datos sobre variables sociolaborales, clínicas y de exposición de interés. La detección de anticuerpos IgG e IgM anti-SARS-CoV-2 se realizó a partir de muestras de suero, mediante ensayos inmunoenzimáticos indirectos. Resultados: La prevalencia de IgG anti-SARS-CoV-2 fue 7,6 veces mayor en la fase de circulación viral respecto a la fase de remisión (2,1 % vs. 15,9 %, respectivamente); no se detectó IgM. Respecto al nivel de riesgo de exposición en el ámbito laboral, la mayor prevalencia acumulada se registró en el grupo de alto riesgo (tiene contacto con pacientes y “trabaja en la Unidad de Cuidados Intensivos [UCI]” o “trabaja en Área COVID-19” o “trabaja en Emergencia”), con 26,7 % de casos reactivos. Casi un tercio de los trabajadores señaló no usar siempre los equipos de protección personal recomendados y menos del 10 % declaró haberlos usado en su totalidad, independientemente del nivel de riesgo de exposición. La seroprevalencia en PS que no reportó síntomas desde el inicio del Aislamiento Social Preventivo y Obligatorio fue del 12,3 % en la fase de remisión, y del 10,0 % en aquellos trabajadores con antecedente de resultado RT-PCR negativo (p < 0,05). Conclusiones: Complementar la vigilancia epidemiológica pasiva con la vigilancia serológica activa mediante ensayos sencillos y económicos es importante para adecuar eficazmente las estrategias de mitigación en poblaciones vulnerables como el PS.
- 12 March 2025
- Published by Universidad de San Martin de Porres in Horizonte Médico (Lima)
- Vol. 25 (1) , e2923
Open AccessSeroprevalencia de infección por SARS-COV-2 en personal de salud del Gran Santa Fé (Argentina) durante la pandemia de COVID-19
Objetivo: Estimar la prevalencia de infección por el coronavirus del síndrome respiratorio agudo grave de tipo 2 (SARS-CoV-2) mediante la determinación de anticuerpos en Personal de Salud (PS) del Gran Santa Fe (Argentina), en una fase de circulación viral sostenida y una fase de remisión. Materiales y Métodos: Se realizó un estudio longitudinal, seroepidemiológico y de base poblacional. La población objetivo estuvo constituida por el PS que se desempeñó en establecimientos de salud del subsector público, de segundo y tercer nivel, dentro del Gran Santa Fe. El tamaño muestral fue de 600 trabajadores de la salud activos, distribuidos proporcionalmente entre los establecimientos de salud seleccionados. Se aplicó un cuestionario autoadministrado para obtener datos sobre variables sociolaborales, clínicas y de exposición de interés. La detección de anticuerpos IgG e IgM anti-SARS-CoV-2 se realizó a partir de muestras de suero, mediante ensayos inmunoenzimáticos indirectos. Resultados: La prevalencia de IgG anti-SARS-CoV-2 fue 7,6 veces mayor en la fase de circulación viral respecto a la fase de remisión (2,1 % vs. 15,9 %, respectivamente); no se detectó IgM. Respecto al nivel de riesgo de exposición en el ámbito laboral, la mayor prevalencia acumulada se registró en el grupo de alto riesgo (tiene contacto con pacientes y “trabaja en la Unidad de Cuidados Intensivos [UCI]” o “trabaja en Área COVID-19” o “trabaja en Emergencia”), con 26,7 % de casos reactivos. Casi un tercio de los trabajadores señaló no usar siempre los equipos de protección personal recomendados y menos del 10 % declaró haberlos usado en su totalidad, independientemente del nivel de riesgo de exposición. La seroprevalencia en PS que no reportó síntomas desde el inicio del Aislamiento Social Preventivo y Obligatorio fue del 12,3 % en la fase de remisión, y del 10,0 % en aquellos trabajadores con antecedente de resultado RT-PCR negativo (p < 0,05). Conclusiones: Complementar la vigilancia epidemiológica pasiva con la vigilancia serológica activa mediante ensayos sencillos y económicos es importante para adecuar eficazmente las estrategias de mitigación en poblaciones vulnerables como el PS.
- 15 June 2018
- Published by Instituto Nacional de Salud (Colombia) in Biomédica
- Vol. 38 (2) , 180-188
Tuberculosis and comorbidities in urban areas in Argentina. A gender and age perspective
Introducción. La tuberculosis continúa siendo un importante problema de salud en el mundo, con una incidencia de más de 10 millones de casos en el 2015. Hay factores que modifican el riesgo de desarrollar la enfermedad luego de contraer la infección, así como su forma de presentación.Objetivo. Determinar las principales comorbilidades y características demográficas, clínicas y microbiológicas de pacientes adultos con tuberculosis en Argentina, mediante un análisis desde la perspectiva de sexo y edad.Materiales y métodos. Se llevó a cabo un estudio transversal en hospitales de referencia para pacientes de áreas urbanas con tuberculosis. Se incluyeron pacientes de 15 años o más con tuberculosis pulmonar o extrapulmonar, confirmada bacteriológicamente y en tratamiento hospitalario o ambulatorio, y también, pacientes sin confirmación bacteriológica, pero con características clínicas y radiológicas indicativas de tuberculosis. El período de estudio fue del 1º de agosto de 2015 al 31 de agosto de 2016.Resultados. Se incluyeron 378 pacientes. La mediana de edad fue de 37 años. El sexo masculino estuvo asociado con tuberculosis extrapulmonar, hospitalización, tabaquismo, adicción a drogas y alcoholismo. Los menores de 40 años presentaron adicción a drogas y bajo peso con mayor frecuencia, en tanto que los de 40 años o más presentaron, en mayor proporción, diabetes, alcoholismo y enfermedad pulmonar obstructiva crónica (EPOC). Se observaron más casos de sida en el sexo masculino, y en edades de 40 años y más. Conclusiones. Este trabajo permitió conocer las características y las comorbilidades de enfermos de tuberculosis, que influyen en el desarrollo y la evolución de la enfermedad, desde una perspectiva de edad y sexo, con el objetivo de facilitar enfoques de manejo que incorporan aspectos sociales y comunitarios.
- 15 June 2018
- Published by Instituto Nacional de Salud (Colombia) in Biomédica
- Vol. 38 (2) , 180-188
Tuberculosis and comorbidities in urban areas in Argentina. A gender and age perspective
Introducción. La tuberculosis continúa siendo un importante problema de salud en el mundo, con una incidencia de más de 10 millones de casos en el 2015. Hay factores que modifican el riesgo de desarrollar la enfermedad luego de contraer la infección, así como su forma de presentación.Objetivo. Determinar las principales comorbilidades y características demográficas, clínicas y microbiológicas de pacientes adultos con tuberculosis en Argentina, mediante un análisis desde la perspectiva de sexo y edad.Materiales y métodos. Se llevó a cabo un estudio transversal en hospitales de referencia para pacientes de áreas urbanas con tuberculosis. Se incluyeron pacientes de 15 años o más con tuberculosis pulmonar o extrapulmonar, confirmada bacteriológicamente y en tratamiento hospitalario o ambulatorio, y también, pacientes sin confirmación bacteriológica, pero con características clínicas y radiológicas indicativas de tuberculosis. El período de estudio fue del 1º de agosto de 2015 al 31 de agosto de 2016.Resultados. Se incluyeron 378 pacientes. La mediana de edad fue de 37 años. El sexo masculino estuvo asociado con tuberculosis extrapulmonar, hospitalización, tabaquismo, adicción a drogas y alcoholismo. Los menores de 40 años presentaron adicción a drogas y bajo peso con mayor frecuencia, en tanto que los de 40 años o más presentaron, en mayor proporción, diabetes, alcoholismo y enfermedad pulmonar obstructiva crónica (EPOC). Se observaron más casos de sida en el sexo masculino, y en edades de 40 años y más. Conclusiones. Este trabajo permitió conocer las características y las comorbilidades de enfermos de tuberculosis, que influyen en el desarrollo y la evolución de la enfermedad, desde una perspectiva de edad y sexo, con el objetivo de facilitar enfoques de manejo que incorporan aspectos sociales y comunitarios.
- 11 May 2018
- Published by Springer Nature in International Journal of Peptide Research and Therapeutics
- Vol. 25 (2) , 691-696
Analogues of Human Granulysin as Antimycobacterial Agents
- 11 May 2018
- Published by Springer Nature in International Journal of Peptide Research and Therapeutics
- Vol. 25 (2) , 691-696
Analogues of Human Granulysin as Antimycobacterial Agents
- 1 January 2017
- Vol. 77 (4) , 267-273
Risk factors associated with tuberculosis mortality in adults in six provinces of Argentina.
Tuberculosis (TB) remains a cause of illness and death across the world, especially in developing countries and vulnerable population groups. In 2013, 1.5 million died from the disease worldwide. In Argentina, the largest proportion of TB-related deaths occurred in the northern provinces. Several international studies reported that TB mortality was related to the presence of certain comorbidities and socio-demographic characteristics. Our aim was to investigate the main risk factors associated with TB mortality in adults from six provinces in Argentina, especially those with higher TB mortality rates. A retrospective case-control study was conducted. It included all patients of =18 years with clinical and/or bacteriological TB diagnosis who underwent treatment from January 1st, 2012 to June 30th, 2013. Socio-demographic, clinical and bacteriological variables were surveyed. Information on 157 cases and 281 controls was obtained. Patients reported as deceased to the TB Control Program were considered cases, and those whose treatment result was reported as successful in the same time period were considered controls. For 111 deaths, the average time elapsed between the start of treatment and death was 2.3 months; median: 1. TB-related mortality was associated with poor TB treatment adherence (OR: 3.7 [1.9-7.3], p: 0.000), AIDS (OR: 5.29 [2.6-10.7], p: 0.000), male gender (OR: 1.7 [1.1-2.5], p: 0.009), belonging to indigenous people (OR: 7.2 [2.8-18.9], p:0. 000) and age = 50 (OR: 2.2 [1.4-3.3], p: 0.000). By multivariate analysis the two first associations were confirmed. This study sets up the basis for planning inter-program and inter-sector work to accelerate the decline in the inequitable TB mortality.
- 1 January 2017
- Vol. 77 (4) , 267-273
Risk factors associated with tuberculosis mortality in adults in six provinces of Argentina.
Tuberculosis (TB) remains a cause of illness and death across the world, especially in developing countries and vulnerable population groups. In 2013, 1.5 million died from the disease worldwide. In Argentina, the largest proportion of TB-related deaths occurred in the northern provinces. Several international studies reported that TB mortality was related to the presence of certain comorbidities and socio-demographic characteristics. Our aim was to investigate the main risk factors associated with TB mortality in adults from six provinces in Argentina, especially those with higher TB mortality rates. A retrospective case-control study was conducted. It included all patients of =18 years with clinical and/or bacteriological TB diagnosis who underwent treatment from January 1st, 2012 to June 30th, 2013. Socio-demographic, clinical and bacteriological variables were surveyed. Information on 157 cases and 281 controls was obtained. Patients reported as deceased to the TB Control Program were considered cases, and those whose treatment result was reported as successful in the same time period were considered controls. For 111 deaths, the average time elapsed between the start of treatment and death was 2.3 months; median: 1. TB-related mortality was associated with poor TB treatment adherence (OR: 3.7 [1.9-7.3], p: 0.000), AIDS (OR: 5.29 [2.6-10.7], p: 0.000), male gender (OR: 1.7 [1.1-2.5], p: 0.009), belonging to indigenous people (OR: 7.2 [2.8-18.9], p:0. 000) and age = 50 (OR: 2.2 [1.4-3.3], p: 0.000). By multivariate analysis the two first associations were confirmed. This study sets up the basis for planning inter-program and inter-sector work to accelerate the decline in the inequitable TB mortality.
- 22 January 2015
- Vol. 56 (4) , 311-2
[In Process Citation].
- 1 January 2015
- Vol. 75 (3) , 147-54
[Trends of tuberculosis in the Fifth Health Region, Buenos Aires Province, years 2000-2011].
The aim of this study was to describe the trends in tuberculosis (TB) in the Fifth Health Region (RSV) in the Buenos Aires Province. A trend study allowed the evaluation of the average variation of change in the incidence rate (IR) using simple linear regression expressed as a mean annual variation (VAP). The number of reported TB cases and IR per 100 000 population of all TB cases, pulmonary TB (PTB) and bacteriologically confirmed PTB from January 1, 2000 to December 31, 2011, were analyzed by age groups: 0-14; 15-29 and over 64 years of age. The decline in IR was less than 5% for all forms of TB and lower for bacteriologically confirmed PTB cases. The highest rate of PTB and IR was concentrated in the age group of 15-29 years with stable or slightly increasing trend of IR in bacteriologically confirmed PTB. There were similar trends for bacteriologically confirmed PTB in children. The fastest decline in PTB IR occurred in 0-14 age group, while for cases over 64 years of age the decline was sustained over time. TB continues to be a health risk in RSV, with cases in younger age groups. Therefore, it remains necessary to strengthen TB control activities in this region.
- 1 January 2015
- Vol. 75 (3) , 147-54
[Trends of tuberculosis in the Fifth Health Region, Buenos Aires Province, years 2000-2011].
The aim of this study was to describe the trends in tuberculosis (TB) in the Fifth Health Region (RSV) in the Buenos Aires Province. A trend study allowed the evaluation of the average variation of change in the incidence rate (IR) using simple linear regression expressed as a mean annual variation (VAP). The number of reported TB cases and IR per 100 000 population of all TB cases, pulmonary TB (PTB) and bacteriologically confirmed PTB from January 1, 2000 to December 31, 2011, were analyzed by age groups: 0-14; 15-29 and over 64 years of age. The decline in IR was less than 5% for all forms of TB and lower for bacteriologically confirmed PTB cases. The highest rate of PTB and IR was concentrated in the age group of 15-29 years with stable or slightly increasing trend of IR in bacteriologically confirmed PTB. There were similar trends for bacteriologically confirmed PTB in children. The fastest decline in PTB IR occurred in 0-14 age group, while for cases over 64 years of age the decline was sustained over time. TB continues to be a health risk in RSV, with cases in younger age groups. Therefore, it remains necessary to strengthen TB control activities in this region.
- Open Access
- 31 October 2012
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 7 (10) , e47540
Mortality, Severe Acute Respiratory Infection, and Influenza-Like Illness Associated with Influenza A(H1N1)pdm09 in Argentina, 2009
While there is much information about the burden of influenza A(H1N1)pdm09 in North America, little data exist on its burden in South America. During April to December 2009, we actively searched for persons with severe acute respiratory infection and influenza-like illness (ILI) in three sentinel cities. A proportion of case-patients provided swabs for influenza testing. We estimated the number of case-patients that would have tested positive for influenza by multiplying the number of untested case-patients by the proportion who tested positive. We estimated rates by dividing the estimated number of case-patients by the census population after adjusting for the proportion of case-patients with missing illness onset information and ILI case-patients who visited physicians multiple times for one illness event. We estimated that the influenza A(H1N1)pdm09 mortality rate per 100,000 person-years (py) ranged from 1.5 among persons aged 5–44 years to 5.6 among persons aged ≥65 years. A(H1N1)pdm09 hospitalization rates per 100,000 py ranged between 26.9 among children aged <5 years to 41.8 among persons aged ≥65 years. Influenza A(H1N1)pdm09 ILI rates per 100 py ranged between 1.6 among children aged <5 to 17.1 among persons aged 45–64 years. While 9 (53%) of 17 influenza A(H1N1)pdm09 decedents with available data had obesity and 7 (17%) of 40 had diabetes, less than 4% of surviving influenza A(H1N1)pdm09 case-patients had these pre-existing conditions (p≤0.001). Influenza A(H1N1)pdm09 caused a similar burden of disease in Argentina as in other countries. Such disease burden suggests the potential value of timely influenza vaccinations.
- 31 October 2012
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 7 (10) , e47540
Open AccessMortality, Severe Acute Respiratory Infection, and Influenza-Like Illness Associated with Influenza A(H1N1)pdm09 in Argentina, 2009
While there is much information about the burden of influenza A(H1N1)pdm09 in North America, little data exist on its burden in South America. During April to December 2009, we actively searched for persons with severe acute respiratory infection and influenza-like illness (ILI) in three sentinel cities. A proportion of case-patients provided swabs for influenza testing. We estimated the number of case-patients that would have tested positive for influenza by multiplying the number of untested case-patients by the proportion who tested positive. We estimated rates by dividing the estimated number of case-patients by the census population after adjusting for the proportion of case-patients with missing illness onset information and ILI case-patients who visited physicians multiple times for one illness event. We estimated that the influenza A(H1N1)pdm09 mortality rate per 100,000 person-years (py) ranged from 1.5 among persons aged 5–44 years to 5.6 among persons aged ≥65 years. A(H1N1)pdm09 hospitalization rates per 100,000 py ranged between 26.9 among children aged <5 years to 41.8 among persons aged ≥65 years. Influenza A(H1N1)pdm09 ILI rates per 100 py ranged between 1.6 among children aged <5 to 17.1 among persons aged 45–64 years. While 9 (53%) of 17 influenza A(H1N1)pdm09 decedents with available data had obesity and 7 (17%) of 40 had diabetes, less than 4% of surviving influenza A(H1N1)pdm09 case-patients had these pre-existing conditions (p≤0.001). Influenza A(H1N1)pdm09 caused a similar burden of disease in Argentina as in other countries. Such disease burden suggests the potential value of timely influenza vaccinations.
- 1 February 2012
- Published by SAGE Publications in Foodborne Pathogens and Disease
- Vol. 9 (2) , 132-137
Detection of Mycobacterium bovis –Infected Dairy Herds Using PCR in Bulk Tank Milk Samples
Bovine tuberculosis (bTB) is a chronic and zoonotic disease due to Mycobacterium bovis. The tuberculosis eradication campaign carried out in Argentina has considerably improved the health situation of the herds. Here we evaluated a strategy to detect M. bovis–infected herds by Touch-Down IS6110 polymerase chain reaction (PCR) in bulk tank raw milk from dairy farms. We evaluated 177 samples from herds with the official tuberculosis free certificate (TFC) and 80 from herds without the certificate, non-tuberculosis-free certificate (NTFC), from 10 departments of Santa Fe province, Argentina. To avoid the effect of Taq polymerase inhibitors, a dilution of DNA template was performed. Positive PCR results were obtained in 102 (40%) of the samples, whereas negative ones were obtained in 155 (60%) of the samples. Importantly, 44% of NTFC and 38% of TFC samples were positive. All samples were subjected to culture in Löwenstein Jensen and Stonebrink media with no positive isolation. The negative predictive value (NPV) of PCR in the TFC group was 95%, while the positive predictive value (PPV) of PCR in the NTFC group was 51%. Based on these results, this work proposes a method that should be applied regularly to detect M. bovis--infected dairy herds, complementary to the official test of tuberculin, or purifed protein derivative (PPD), to control dairy herds, especially those free of tuberculosis.
- 1 February 2012
- Published by SAGE Publications in Foodborne Pathogens and Disease
- Vol. 9 (2) , 132-137
Detection of Mycobacterium bovis –Infected Dairy Herds Using PCR in Bulk Tank Milk Samples
Bovine tuberculosis (bTB) is a chronic and zoonotic disease due to Mycobacterium bovis. The tuberculosis eradication campaign carried out in Argentina has considerably improved the health situation of the herds. Here we evaluated a strategy to detect M. bovis–infected herds by Touch-Down IS6110 polymerase chain reaction (PCR) in bulk tank raw milk from dairy farms. We evaluated 177 samples from herds with the official tuberculosis free certificate (TFC) and 80 from herds without the certificate, non-tuberculosis-free certificate (NTFC), from 10 departments of Santa Fe province, Argentina. To avoid the effect of Taq polymerase inhibitors, a dilution of DNA template was performed. Positive PCR results were obtained in 102 (40%) of the samples, whereas negative ones were obtained in 155 (60%) of the samples. Importantly, 44% of NTFC and 38% of TFC samples were positive. All samples were subjected to culture in Löwenstein Jensen and Stonebrink media with no positive isolation. The negative predictive value (NPV) of PCR in the TFC group was 95%, while the positive predictive value (PPV) of PCR in the NTFC group was 51%. Based on these results, this work proposes a method that should be applied regularly to detect M. bovis--infected dairy herds, complementary to the official test of tuberculin, or purifed protein derivative (PPD), to control dairy herds, especially those free of tuberculosis.
- 1 April 2010
- Published by Bentham Science Publishers Ltd. in Protein & Peptide Letters
- Vol. 17 (4) , 517-521
Bactericidal and Hemolytic Activities of Synthetic Peptides Derived from Granulysin
Granulysin is a human polypeptide produced by cytolytic cells active against a broad range of microbes. Three peptides covering the regions 25-50 (Gr-1 and Gr-2) and 39-62 (Gr-3) of granulysin were synthesized, and their in vitro activity against Mycobacterium tuberculosis was evaluated. The most active peptide was Gr-1C, containing a disulphide bridge, with Minimal Inhibitory Concentration value of 10.1 μM. In concentrations of up to 50 μM, Gr-1 and Gr2 didnt exceed 30% of hemolysis.
- 1 April 2010
- Published by Bentham Science Publishers Ltd. in Protein & Peptide Letters
- Vol. 17 (4) , 517-521
Bactericidal and Hemolytic Activities of Synthetic Peptides Derived from Granulysin
Granulysin is a human polypeptide produced by cytolytic cells active against a broad range of microbes. Three peptides covering the regions 25-50 (Gr-1 and Gr-2) and 39-62 (Gr-3) of granulysin were synthesized, and their in vitro activity against Mycobacterium tuberculosis was evaluated. The most active peptide was Gr-1C, containing a disulphide bridge, with Minimal Inhibitory Concentration value of 10.1 μM. In concentrations of up to 50 μM, Gr-1 and Gr2 didnt exceed 30% of hemolysis.
- 1 January 2008
- Vol. 12 (1) , 63-8
Delay in tuberculosis diagnosis and treatment in four provinces of Argentina.
Public health care services in the provinces of Buenos Aires, Santa Fe, Jujuy and Santa Cruz, Argentina. To evaluate delays in tuberculosis (TB) diagnosis and treatment and associated risk factors in departments and administrative areas of four Argentine provinces. Cross-sectional survey including retrospective medical record review and patient interviews. A total of 243 patients with smear-positive pulmonary TB and a mean age of 40 years were included in the study. The mean diagnostic delays were as follows: total delay 92.1 days (median 62.0); patient delay 58.8 days (median 31); health service delay 32.6 days (median 12.5). The mean treatment delay was 0.9 days (median 0). Associations were observed between patient delays of >30 days and residence in Jujuy, age >50 years, dependence on transport to the nearest public health service due to distance and presence of cough. The >60-day total diagnosis delay was associated with age >50 years and need for transport to the nearest public health service. Diagnostic delay is an important problem in the areas studied, with patient delay being of most concern. Patient delay was associated with age >50 years, dependence on transport to the nearest public health service due to distance and presence of cough.
- 1 January 2008
- Vol. 12 (1) , 63-8
Delay in tuberculosis diagnosis and treatment in four provinces of Argentina.
Public health care services in the provinces of Buenos Aires, Santa Fe, Jujuy and Santa Cruz, Argentina. To evaluate delays in tuberculosis (TB) diagnosis and treatment and associated risk factors in departments and administrative areas of four Argentine provinces. Cross-sectional survey including retrospective medical record review and patient interviews. A total of 243 patients with smear-positive pulmonary TB and a mean age of 40 years were included in the study. The mean diagnostic delays were as follows: total delay 92.1 days (median 62.0); patient delay 58.8 days (median 31); health service delay 32.6 days (median 12.5). The mean treatment delay was 0.9 days (median 0). Associations were observed between patient delays of >30 days and residence in Jujuy, age >50 years, dependence on transport to the nearest public health service due to distance and presence of cough. The >60-day total diagnosis delay was associated with age >50 years and need for transport to the nearest public health service. Diagnostic delay is an important problem in the areas studied, with patient delay being of most concern. Patient delay was associated with age >50 years, dependence on transport to the nearest public health service due to distance and presence of cough.